NRX Pharmaceuticals Inc (NRXP): Next-Year EPS Estimate 239.30%
As of 2026-06-04, NRX Pharmaceuticals Inc (NRXP) has a next-year EPS growth estimate of 239.30%.
On 2026-05-28, analyst consensus for NRXP's next-year EPS growth shifted from 274.70% to 239.30% — a negative change of 35.40 percentage points. The revised estimate has been sustained across 6 subsequent trading sessions. Current-year growth is projected at 87.50%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 239.30%
- EPS growth this year
- 87.50%
- EPS next quarter (est)
- -$0.07
- Last price
- $4.05
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 239.30% | 87.50% | -$0.07 | $4.05 |
| 2026-06-03 | 239.30% | 87.50% | -$0.07 | $4.05 |
| 2026-06-02 | 239.30% | 87.50% | -$0.07 | $4.62 |
| 2026-06-01 | 239.30% | 87.50% | -$0.07 | $4.62 |
| 2026-05-31 | 239.30% | 87.50% | -$0.07 | $4.42 |
| 2026-05-28 | 239.30% | 87.50% | -$0.07 | $4.44 |
| 2026-05-27 | 274.70% | 139.27% | $0.06 | $4.28 |
| 2026-05-26 | 274.70% | 139.27% | $0.06 | $4.31 |
| 2026-05-25 | 274.70% | 139.27% | $0.06 | $3.22 |
| 2026-05-24 | 274.70% | 139.27% | $0.06 | $3.22 |
| 2026-05-21 | 274.70% | 139.27% | $0.06 | $3.06 |
| 2026-05-20 | 274.70% | 139.27% | $0.06 | $2.97 |
| 2026-05-19 | 274.70% | 139.27% | $0.06 | $3.03 |
| 2026-05-18 | 274.70% | 139.27% | $0.06 | $3.12 |
| 2026-05-17 | 272.81% | 139.42% | $0.21 | $3.28 |
| 2026-05-14 | 272.81% | 139.42% | $0.21 | $3.21 |
| 2026-05-13 | 272.81% | 139.42% | $0.21 | $2.98 |
| 2026-05-12 | 270.05% | 156.18% | $0.29 | $2.87 |
| 2026-05-11 | 270.05% | 156.18% | $0.29 | $2.82 |
| 2026-05-10 | 270.05% | 156.18% | $0.29 | $3.08 |
| 2026-05-07 | 270.05% | 156.18% | $0.29 | $3.06 |
| 2026-05-06 | 270.05% | 156.18% | $0.29 | $3.05 |
| 2026-05-05 | 270.05% | 156.18% | $0.29 | $3.04 |
| 2026-05-04 | 270.05% | 156.18% | $0.29 | $3.00 |
| 2026-05-03 | 270.05% | 156.18% | $0.29 | $3.09 |
| 2026-04-30 | 270.05% | 156.18% | $0.29 | $2.98 |
| 2026-04-29 | 270.05% | 156.18% | $0.29 | $2.91 |
| 2026-04-28 | 270.05% | 156.18% | $0.29 | $2.95 |
| 2026-04-27 | 270.05% | 156.18% | $0.29 | $3.03 |
| 2026-04-26 | 249.85% | 183.83% | $0.42 | $2.94 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is NRX Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-04, NRX Pharmaceuticals Inc (NRXP) has a next-year EPS growth estimate of 239.30%, based on analyst consensus.
When was the latest EPS estimate revision for NRXP?▾
The most recent revision occurred on 2026-05-28, when analysts adjusted the next-year EPS growth estimate from 274.70% to 239.30%.
What sector and industry does NRX Pharmaceuticals Inc belong to?▾
NRX Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NRXP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. NRX Pharmaceuticals Inc (NRXP) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports